HUMAN REPRODUCTION is a prestigious academic journal published by Oxford University Press, dedicated to advancing the field of reproductive medicine. With an impressive impact factor highlighting its significance, the journal ranks in the top quartile (Q1) for Obstetrics and Gynecology, Rehabilitation, and Reproductive Medicine, showcasing its crucial role in disseminating high-quality research. Founded in 1986, it has become a key resource for researchers, practitioners, and students interested in cutting-edge developments and innovative practices in human reproduction. Despite not currently offering open access, the journal continues to publish a wealth of peer-reviewed articles that contribute substantially to clinical knowledge and practice. With Scopus rankings placing it among the top journals in its categories, HUMAN REPRODUCTION remains an essential platform for discussion and dissemination of vital findings impacting reproductive health globally.

HUMAN REPRODUCTION UPDATE, published by Oxford University Press, stands as a leading journal in the fields of Obstetrics and Gynecology and Reproductive Medicine. With an impressive Q1 ranking in both categories according to the 2023 category quartiles and a significant Scopus rank, it is recognized as one of the top journals globally in these disciplines, catering to the most relevant and cutting-edge research. The journal has been a crucial platform for disseminating vital findings and reviews from 1995 to 2024, contributing to advancements in human reproductive health. With its focus on publishing high-quality, peer-reviewed articles, it serves as an essential resource for researchers, healthcare professionals, and students seeking the latest insights and developments in reproductive science. As the journal aims to foster informed discussions and encourage further research, it remains committed to shaping the future of reproductive health and medicine.

JOURNAL OF MOLECULAR ENDOCRINOLOGY, published by BIOSCIENTIFICA LTD, is a prestigious academic journal that has made significant contributions to the fields of endocrinology and molecular biology since its inception in 1988. With an impressive impact factor that places it in the Q1 category for Endocrinology and Q2 for Molecular Biology, this journal is recognized for its rigorous peer-reviewed research that addresses key questions at the intersection of molecular mechanisms and hormonal regulation. The journal's accessibility within the Scopus rankings, notably positioned 45th out of 128 in Endocrinology, highlights its relevance and influence in shaping contemporary scientific discourse. Although the journal does not currently offer open access options, it remains an essential resource for researchers, professionals, and students eager to explore groundbreaking discoveries and advancements in the hormonal sciences. The JOURNAL OF MOLECULAR ENDOCRINOLOGY continues to pave the way for critical exploration and innovation, ensuring its place as a vital publication for the advancement of knowledge in molecular endocrinology.

Reproductive Biomedicine Online, published by Elsevier, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Developmental Biology, Obstetrics and Gynecology, and Reproductive Medicine. With an impressive Impact Factor and a Q1 ranking in its respective disciplines as of 2023, this journal provides a platform for innovative research and comprehensive reviews that contribute to advancements in reproductive healthcare. The journal boasts rigorous Scopus rankings, placing it within the top tiers of its categories, which underscores its significance in shaping contemporary biomedical inquiry. Although not open access, it remains widely accessible through institutional subscriptions, making its wealth of knowledge available to researchers, clinicians, and students alike. Since its inception in 2000, Reproductive Biomedicine Online has been committed to fostering a deeper understanding of reproductive processes and biomedicine, ensuring that its content remains relevant and impactful in addressing challenges in reproductive health, thereby championing exceptional scientific discourse.

Reproduction, Fertility and Development, published by CSIRO Publishing, is a prestigious journal that has been at the forefront of research in the fields of reproductive science, developmental biology, and related disciplines since its inception in 1989. With an ISSN of 1031-3613 and an E-ISSN of 1448-5990, this journal serves as a vital platform for disseminating innovative findings and methodologies that advance our understanding of reproductive processes and development in a variety of organisms. The journal is indexed in prominent databases, exhibiting a solid standing with a Q3 quartile ranking in both Animal Science and Zoology and Biotechnology, and covering 2023 rankings in multiple related categories. Operating from Australia, Reproduction, Fertility and Development embraces a commitment to enriching scholarly communication and fostering collaborative research efforts. Its focus on high-quality, peer-reviewed articles makes it an essential resource for researchers, professionals, and students seeking to stay abreast of the latest advancements and pivotal discussions in reproductive medicine and developmental biology.

Reproductive Medicine and Biology, an esteemed journal published by WILEY, stands at the forefront of advancements in the field of reproductive health and associated biological sciences. With an impact factor that underscores its relevance—ranking in Q1 for Reproductive Medicine and Q3 in Cell Biology—this journal is distinguished by its commitment to disseminating high-quality, peer-reviewed research since its transition to Open Access in 2002. Based in Japan, the journal caters to a global audience, providing vital insights into reproductive biology, therapeutics, and innovative practices. With Scopus rankings placing it at #22 out of 90 in Reproductive Medicine and a commendable percentile ranking, Reproductive Medicine and Biology aims to foster dialogue and knowledge transfer among researchers, professionals, and students, paving the way for breakthroughs in understanding reproductive health.

The Journal of Assisted Reproduction and Genetics, published by Springer/Plenum Publishers, serves as a pivotal platform for innovative research and advancements in the fields of reproductive medicine, genetics, and developmental biology. With an impact factor that positions it within the upper echelon of its categories—including Q1 rankings in Obstetrics and Gynecology and Reproductive Medicine—this journal plays a critical role in disseminating high-quality, peer-reviewed studies that significantly influence clinical practices and research directions. Renowned for its commitment to enhancing understanding in areas such as assisted reproductive technologies, genetic screening, and reproductive health, the journal attracts contributions from leading experts worldwide. With a broad scope encompassing original research, case studies, and comprehensive reviews, the Journal of Assisted Reproduction and Genetics continues to be an essential resource for researchers, healthcare professionals, and students dedicated to the advancement of reproductive sciences.

The International Journal of Reproductive Biomedicine, an esteemed publication by SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, serves as a pivotal platform in the fields of obstetrics and gynecology as well as reproductive medicine. Established in 2011 and transitioning to an open access model in 2015, this journal facilitates the dissemination of innovative research and critical findings to a global audience, particularly focusing on advancements in reproductive health and biomedicine. With an impact factor reflective of its commitment to high-quality scientific inquiry, the journal has achieved a notable ranking of Q3 in both its categories for 2023, contributing to its growing influence within the academic community. Researchers and professionals benefit from its broad scope, which encompasses a range of topics essential to reproductive health, thus fostering a rich exchange of knowledge. The journal's accessibility allows students and professionals alike to engage with the latest findings and contribute to ongoing discussions within this vital field of study.

Reproductive Biology is a premier academic journal published by Elsevier, dedicated to advancing the field of reproductive science. With an ISSN of 1642-431X and an E-ISSN of 2300-732X, this journal has been serving the scientific community since its inception in 2001. It notably holds a Q1 ranking in Animal Science and Zoology as of 2023, underscoring its significant impact and prominence in this domain. The journal encompasses a wide array of topics surrounding reproductive biology, including but not limited to endocrinology and developmental processes, making it an essential resource for researchers and practitioners. Although it operates under a traditional access model, its comprehensive scope offers valuable insights that contribute to advancements in reproductive health, animal conservation, and biotechnology. Published in the Netherlands, Reproductive Biology aims to foster interdisciplinary collaboration and innovation, ultimately enriching our understanding of reproductive mechanisms across various species. Researchers, professionals, and students alike will find this journal an indispensable platform for disseminating groundbreaking research and engaging with the latest findings in reproductive science.

ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.